Once-weekly 22microg subcutaneous IFN-beta-1a in secondary progressive MS: a 3-year follow-up study on brain MRI measurements and serum MMP-9 levels.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples